CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
FORMAC Pharmaceuticals NV is developing a drug delivery technology that enhances the oral absorption of poorly soluble drugs using Ordered Mesoporous Silica materials. This platform aims to facilitate the formulation of oral drug products for various pharmaceutical applications.
FORMAC Pharmaceuticals NV is actively developing and commercialising an innovative and proprietary drug delivery technology to increase the oral bioavailability of poorly aqueous soluble drugs.
Those molecules represent up to seventy percent of the compounds in discovery pipelines and up to forty percent of the currently marketed drugs.
Based on the use of Ordered Mesoporous Silica (OMS) materials, FORMAC’s platform enables clients’ molecules to be formulated as oral drug products for early dev…
FORMAC PHARMACEUTICALS NV
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
